119 related articles for article (PubMed ID: 618863)
61. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.
Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST
J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924
[TBL] [Abstract][Full Text] [Related]
62. Antithrombin-mediated anticoagulant activity of sulfated polysaccharides: different mechanisms for heparin and sulfated galactans.
Melo FR; Pereira MS; Foguel D; Mourão PA
J Biol Chem; 2004 May; 279(20):20824-35. PubMed ID: 14996843
[TBL] [Abstract][Full Text] [Related]
63. The isolation and partial characterization of glycolipids of normal human leucocytes.
Miras CJ; Mantzos JD; Levis GM
Biochem J; 1966 Mar; 98(3):782-6. PubMed ID: 5911526
[TBL] [Abstract][Full Text] [Related]
64. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
65. Activity toward thrombin-antithrombin of heparin immobilized on two hydrogels.
Tay SW; Merrill EW; Salzman EW; Lindon J
Biomaterials; 1989 Jan; 10(1):11-5. PubMed ID: 2713428
[TBL] [Abstract][Full Text] [Related]
66. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
67. Glycolipid composition of human cataractous lenses. Characterization of Lewisx glycolipids.
Ariga T; Tao RV; Lee BC; Yamawaki M; Yoshino H; Scarsdale NJ; Kasama T; Kushi Y; Yu RK
J Biol Chem; 1994 Jan; 269(4):2667-75. PubMed ID: 7905480
[TBL] [Abstract][Full Text] [Related]
68. Isolation, characterization and nature of carbohydrate-peptide linkage of an alkali-extractable non-collagenous glycoprotein from albino rat skins.
Parthasarathy N; Bose SM
Ital J Biochem; 1977; 26(1):1-11. PubMed ID: 266486
[TBL] [Abstract][Full Text] [Related]
69. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
Hatton MW; Rollason G; Sefton MV
Thromb Haemost; 1983 Dec; 50(4):873-7. PubMed ID: 6198746
[TBL] [Abstract][Full Text] [Related]
70. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
71. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
Björk I; Jackson CM; Jörnvall H; Lavine KK; Nordling K; Salsgiver WJ
J Biol Chem; 1982 Mar; 257(5):2406-11. PubMed ID: 6977539
[TBL] [Abstract][Full Text] [Related]
72. Blood group A activities of glycoprotein and glycolipid from human erythrocyte membranes.
Yamato K; Handa S; Yamakawa T
J Biochem; 1975 Dec; 78(6):1207-14. PubMed ID: 1225920
[TBL] [Abstract][Full Text] [Related]
73. Most clot-bound thrombin activity is inhibited by plasma antithrombin during clot aging, but a very small fraction survives.
Komatsu Y; Hayashi H
Biol Pharm Bull; 2000 Apr; 23(4):502-5. PubMed ID: 10784436
[TBL] [Abstract][Full Text] [Related]
74. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
Griffith MJ
J Biol Chem; 1982 Dec; 257(23):13899-302. PubMed ID: 7142182
[TBL] [Abstract][Full Text] [Related]
75. Carbohydrate composition of lymphocyte plasma membrane from pig mesenteric lymph node.
Snary D; Allen AK; Faulkes RA; Crumpton MJ
Biochem J; 1976 Jan; 153(1):75-8. PubMed ID: 1259716
[TBL] [Abstract][Full Text] [Related]
76. Isolation of wheat germ agglutinin-resistant clones of Chinese hamster ovary cells deficient in membrane sialic acid and galactose.
Briles EB; Li E; Kornfeld S
J Biol Chem; 1977 Feb; 252(3):1107-16. PubMed ID: 320201
[TBL] [Abstract][Full Text] [Related]
77. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
Machovich R; Borsodi A; Blaskó G; Orakzai SA
Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
[TBL] [Abstract][Full Text] [Related]
78. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism.
Preissner KT; Delvos U; Müller-Berghaus G
Biochemistry; 1987 May; 26(9):2521-8. PubMed ID: 3038185
[TBL] [Abstract][Full Text] [Related]
79. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding.
Peterson CB; Morgan WT; Blackburn MN
J Biol Chem; 1987 Jun; 262(16):7567-74. PubMed ID: 3584128
[TBL] [Abstract][Full Text] [Related]
80. Endogenous antithrombin associated with microvascular endothelium. Quantitative analysis in perfused rat hearts.
Felsch JS; Owen WG
Biochemistry; 1994 Jan; 33(3):818-22. PubMed ID: 8292610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
